Biblio
SCGN deficiency is a risk factor for autism spectrum disorder. Signal Transduct Target Ther. 2023;8(1):3.
Glycolysis addiction compensating for a defective pentose phosphate pathway confers gemcitabine sensitivity in SETD2-deficient pancreatic cancer. Biochem Biophys Res Commun. 2022;615:9-16.